(Q50483095)

14 March 2018

title

Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis. (English)

1 reference

14 March 2018

author

Colin M Dayan

11

1 reference

14 March 2018

author name string

T J Creed

1

1 reference

14 March 2018

M R Norman

2

1 reference

14 March 2018

C S J Probert

3

1 reference

14 March 2018

R F Harvey

4

1 reference

14 March 2018

I S Shaw

5

1 reference

14 March 2018

J Smithson

6

1 reference

14 March 2018

J Anderson

7

1 reference

14 March 2018

M Moorghen

8

1 reference

14 March 2018

J Gupta

9

1 reference

14 March 2018

N A Shepherd

10

1 reference

14 March 2018

S D Hearing

12

1 reference

14 March 2018

language of work or name

English

0 references

publication date

1 July 2003

1 reference

14 March 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

14 March 2018

volume

18

1 reference

14 March 2018

page(s)

65-75

1 reference

14 March 2018

issue

1

1 reference

14 March 2018

Further experience in the treatment of severe attacks of ulcerative colitis

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01639.X

p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01639.X

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01639.X

The UK IBDQ-a British version of the inflammatory bowel disease questionnaire. development and validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01639.X

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01639.X

Enhanced response to basiliximab in a patient with aplastic anemia after treatment with standard immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01639.X

Alternate signalling pathways from the interleukin-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01639.X

Functional interactions between Stat5 and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01639.X

Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01639.X

Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01639.X

10.1046/J.1365-2036.2003.01639.X

21 January 2018

Identifiers

DOI

1 reference

14 March 2018

PubMed ID

12848627

1 reference

14 March 2018